rs770499406
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000082.4(ERCC8):c.769G>A(p.Gly257Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000082.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC8 | NM_000082.4 | c.769G>A | p.Gly257Arg | missense_variant | Exon 9 of 12 | ENST00000676185.1 | NP_000073.1 | |
ERCC8 | NM_001007233.3 | c.595G>A | p.Gly199Arg | missense_variant | Exon 10 of 13 | NP_001007234.1 | ||
ERCC8 | NM_001290285.2 | c.310G>A | p.Gly104Arg | missense_variant | Exon 8 of 11 | NP_001277214.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251260Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135814
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461330Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726982
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74272
ClinVar
Submissions by phenotype
not provided Pathogenic:2
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ERCC8 protein function. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 257 of the ERCC8 protein (p.Gly257Arg). This variant is present in population databases (rs770499406, gnomAD 0.01%). This missense change has been observed in individuals with ERCC8-related conditions (PMID: 30182135, 30871974). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 590788). -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36231052, 30871974, 30182135) -
Cockayne syndrome type 1 Pathogenic:1
The p.Gly257Arg variant in ERCC8 was identified in a Chinese consanguineous family with atypical Cockayne syndrome, and was absent in the normal controls. -
Cockayne syndrome Pathogenic:1
Variant summary: ERCC8 c.769G>A (p.Gly257Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251260 control chromosomes. c.769G>A has been reported in the literature as a compound heterozygous genotype in a comprehensively genotyped individual with ultraviolet sensitive syndrome (Li_2019) and as a homozygous genotype in three comprehensively genotyped individuals from a consanguineous family affected with Cockayne-like syndrome, characterized by a combination of spinocerebellar ataxia, skin photosensitivity, and intellectual disability (Zhang_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Cockayne syndrome type 1;C3553298:UV-sensitive syndrome 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at